Emerging Medicines in Multiple Sclerosis
Received Date: Feb 10, 2021 / Accepted Date: Feb 20, 2021 / Published Date: Feb 27, 2021
Abstract
Multiple sclerosis (MS) is a progressive autoimmune neurological condition that mostly affects young adults and may be debilitating. Multiple sclerosis (MS) is currently treated with a number of disease-modifying medications (DMDs) (MS). There has been a surge in the discovery and advancement of possible novel drugs for MS, including oral therapies, in recent years. The aim of this review is to provide concise information on the mechanism of action, signs, symptoms, diagnosis as well as new therapies and medications that may be used off-label in MS.
Keywords: Multiple sclerosis; Symptoms; Diagnosis; Disease-modifying medications; Emerging therapies; Drugs
Citation: Santhosh K (2021) Emerging Medicines in Multiple Sclerosis. J Neuroinfect Dis 12: 320. Doi: 10.4172/2314-7326.1000320
Copyright: © 2021 Santhosh K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Tools
Article Usage
- Total views: 1592
- [From(publication date): 0-2021 - Nov 25, 2024]
- Breakdown by view type
- HTML page views: 975
- PDF downloads: 617
